Vortrag
Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL

Veranstaltungen
04.12.17
16:15 – 17:15
Jena
Jena
Dr. A. Marzinzik
Novartis Institutes for Biomedical Research, Basel/Schweiz

16:15 – 17:15
Jena
Jena
Dr. A. Marzinzik
Novartis Institutes for Biomedical Research, Basel/Schweiz